Daily brief · 2026-11-13
X-energy rose 2.9% after a third-quarter update that added a second Xe-100 engineering contract, while Silex's thin ADR fell 8.8% as uranium and SMR names sold off.
The leader was X-energy (XE), up 2.9% to $11.26 from $10.94, on the fuel-fabrication chokepoint. It reported third-quarter results before the open. The company selected Fluor to advance nuclear engineering and design for a second Xe-100 project. It placed its first procurement order for long-lead steam generator components, with Alleima and Doosan Enerbility. The Xe-100 was accepted into the UK's Generic Design Assessment, and vertical construction of the TX-1 fuel fabrication facility is finished. Liquidity was about $1.8 billion, with no debt. The structural read: TRISO fuel is the strait for every high-temperature gas reactor, and X-energy is building its own. TX-1 is sized for the fuel needs of the first 11 Xe-100s at steady state, and a second project plus long-lead orders turn that fuel plant from a hedge into a supply line.
The laggard was Silex Systems' ADR (SILXY), down 8.8% to $10.93 from $11.98, on the enrichment-and-HALEU chokepoint. The line is thin: about 5,800 shares traded. The home market moved the same way: the Sydney shares closed Friday's session at A$3.08, down from A$3.25 at Wednesday's close. We found no company announcement behind it. The only recent filing we found was a notice, lodged November 11, that Vanguard's stake had fallen below 5%. The structural read: Silex owns 51% of Global Laser Enrichment, a long-dated option on domestic enrichment, and it trades with the uranium tape. Centrus (LEU), the other enrichment name, fell 7.4% to $103.92.
The fuel cycle and the SMR developers fell together, giving back part of the rebound that began with Oklo's results on November 6. The 10-year Treasury yield rose about 10 basis points to roughly 5.1% as bond trading resumed after Veterans Day and absorbed Tuesday's hotter October CPI. NuScale (SMR) fell 7.8% to $4.82, Lightbridge (LTBR) 5.6%, Oklo (OKLO) 5.5% to $24.45 and NANO Nuclear (NNE) 4.3%. In uranium, enCore (EU) fell 6.9%, Uranium Energy (UEC) 5.9%, NexGen (NXE) 5.4%, the Sprott Uranium Miners ETF (URNM) 5.0%, Denison (DNN) 4.6%, the Sprott Physical Uranium Trust (SRUUF) 3.9%, Energy Fuels (UUUU) 3.6% and Cameco (CCJ) 3.4% to $71.78. The operating fleet went the other way: Constellation (CEG) rose 2.8% to $282.40, Talen (TLN) 2.1%, Vistra (VST) 0.8% and PSEG (PEG) 0.7%, while NextEra (NEE) fell 0.8%. Mirion (MIR) and ATI rose 1.4% each, and GE Vernova (GEV) 1.3%. Fluor (FLR) fell 2.2%, Huntington Ingalls (HII) 1.8% and BWX Technologies (BWXT) 1.3%. The S&P 500 fell 0.35% to 7,592.40.
Next up: on the site's calendar, NANO Nuclear's fiscal-year results are due around November 15. The NRC's 18-month review milestone for the Xe-100 construction permit falls on December 16. Westinghouse's definitive agreements with the US government, replacing the binding term sheet, are expected by year-end. The NRC's safety evaluation report for GLE's Paducah laser enrichment facility is anticipated around January 2027.